
With a dedicated focus on gastric ulcer models, our team brings in-depth expertise and knowledge, ensuring precise and reliable results for your drug development needs in this critical area of research.
We adhere to rigorous quality control protocols that comply with GLP standards, ensuring that all preclinical studies meet the highest scientific and ethical standards for your gastric ulcer research.
At our CRO, we understand that every project is unique. We provide tailored preclinical solutions aimed at addressing your specific gastric ulcer drug development challenges and goals.
Our robust operational framework enables us to deliver rapid results without compromising quality, helping you to accelerate your development timelines and bring new treatments to patients more quickly.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china